Monopar Therapeutics (MNPR) Return on Capital Employed Growth (5y) (2023 - 2025)
Monopar Therapeutics (MNPR) Return on Capital Employed Growth (5y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Monopar Therapeutics | 801.51 Mn | 739.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,424.00 |
| Jun 30, 2025 | 1,887.00 |
| Sep 30, 2023 | -9,352.00 |
| Jun 30, 2023 | 8,448.00 |
| Mar 31, 2023 | 7,518.00 |